Radhakrishnan P. Iyer
Geen lopende functies
Loopbaan van Radhakrishnan P. Iyer
Eerdere bekende functies van Radhakrishnan P. Iyer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SPRING BANK PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 07-10-2002 | - |
| Hoofd Techniek/Wetenschap/O&O | 07-10-2002 | 20-11-2020 | |
| Oprichter | 07-10-2002 | 20-11-2020 | |
OriGene Technologies, Inc.
 OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services OriGene Technologies, Inc. engages in the development of products for pharmaceutical, biotechnology, and academic research. It offers CDNA clones, antibodies, assay kits, vectors, RNA Interference (RNAi), tissues, proteins, genome editing, and other products. The company was founded by Wei-Wu He in 1996 and is headquartered in Rockville, MD. | Oprichter | 01-01-1998 | 01-01-2002 |
| Corporate Officer/Principal | 01-01-1998 | 01-01-2002 | |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Hoofd Techniek/Wetenschap/O&O | 01-01-1993 | 01-01-1998 |
| University of Mumbai | Corporate Officer/Principal | - | - |
Opleiding van Radhakrishnan P. Iyer
| University of the Pacific | Doctorate Degree |
| University of Mumbai | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| India | 2 |
| China | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
OriGene Technologies, Inc.
OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services OriGene Technologies, Inc. engages in the development of products for pharmaceutical, biotechnology, and academic research. It offers CDNA clones, antibodies, assay kits, vectors, RNA Interference (RNAi), tissues, proteins, genome editing, and other products. The company was founded by Wei-Wu He in 1996 and is headquartered in Rockville, MD. | Commercial Services |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
